/GSTC
GSTC Stock - GlobeStar Therapeutics Corporation
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.25
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.70
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GSTC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.25
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $77 | $425 |
| Gross Profit | N/A | N/A | $-2,412 | $-37,605 | $271 |
| Gross Margin | N/A | N/A | N/A | -48837.7% | 63.8% |
| Operating Income | $-1,864,000 | $-1,265,000 | $-9,094,000 | $-304,000 | $-316,000 |
| Net Income | $-1,949,000 | $-1,488,000 | $-9,802,000 | $-542,000 | $-675,000 |
| Net Margin | N/A | N/A | N/A | -703896.1% | -158823.5% |
| EPS | $-0.00 | $-0.00 | $-0.02 | $-0.00 | $-0.01 |
Company Overview
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GSTCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2024
EPS Surprise History
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q1 24
No data
Q2 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 11, 2024 | — | $-0.00 | — | — |
Q2 2024 | Jun 28, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 11, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 19, 2024 | — | $-0.00 | — | — |
Q3 2023 | Aug 17, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 13, 2023 | — | $-0.00 | — | — |
Q1 2023 | Jan 9, 2023 | — | $-0.00 | — | — |
Q3 2022 | Aug 22, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 1, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 14, 2022 | — | $-0.00 | — | — |
Q1 2022 | Jan 5, 2022 | — | $-0.01 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 21, 2021 | — | $-0.00 | — | — |
Q1 2021 | Jan 28, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 3, 2020 | — | $-0.00 | — | — |
Q3 2020 | Jul 14, 2020 | — | $-0.00 | — | — |
Q2 2020 | May 5, 2020 | — | $-0.00 | — | — |
Q1 2020 | Feb 14, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GSTC
What is GSTC's current stock price?
GlobeStar Therapeutics Corporation (GSTC) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for GSTC?
No analyst price targets are currently available for this stock.
What sector is GlobeStar Therapeutics Corporation in?
GlobeStar Therapeutics Corporation operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is GSTC's market cap?
GlobeStar Therapeutics Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does GSTC pay dividends?
No, GlobeStar Therapeutics Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUS
Acusphere, Inc.
$0.00
Mkt Cap: $0.0B
AMPE
Ampio Pharmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
BIOAF
Bioasis Technologies Inc.
$0.00
Mkt Cap: $0.0B
EHOS
Ehouse Global, Inc.
$0.00
Mkt Cap: $0.0B
GBLX
GB Sciences, Inc.
$0.00
Mkt Cap: $0.0B
HTDS
Hard to Treat Diseases Inc.
$0.00
Mkt Cap: $0.0B
IRBS
IR Biosciences Holdings Inc.
$0.00
Mkt Cap: $0.0B
PBLA
Panbela Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
RGMP
Regnum Corp.
$0.00
Mkt Cap: $0.0B
SCPX
Scorpius Holdings, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to GSTC for comparison